Nanalysis Scientific Corp. NSCIF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 48.47% | -78.58% | 51.99% | 28.99% | -68.41% |
| Total Depreciation and Amortization | 221.98% | -5.00% | -3.80% | -71.23% | 17.99% |
| Total Amortization of Deferred Charges | -- | 126.06% | -53.15% | -- | -- |
| Total Other Non-Cash Items | 59.14% | -38.06% | 366.33% | -53.69% | -26.79% |
| Change in Net Operating Assets | -28.49% | -112.89% | 1,396.93% | 114.79% | -136.42% |
| Cash from Operations | 646.18% | -105.02% | 947.48% | 80.21% | -160.71% |
| Capital Expenditure | 62.59% | 64.14% | -188.51% | 58.51% | -67.29% |
| Sale of Property, Plant, and Equipment | -- | -12.50% | 2,871.43% | -98.51% | 571.43% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 147.78% | 56.81% | -24.63% | 9.01% | 32.14% |
| Cash from Investing | 137.00% | 61.13% | -33.57% | 4.95% | 33.34% |
| Total Debt Issued | -- | -- | -200.87% | -64.20% | -- |
| Total Debt Repaid | 65.00% | -696.77% | -1,047.22% | 103.23% | 56.11% |
| Issuance of Common Stock | -93.13% | -63.03% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 50.89% | 31.30% | -7.89% | 13.31% | -16.37% |
| Cash from Financing | 54.01% | -474.33% | -22.00% | -53.69% | 159.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.20% | -189.75% | 4,015.24% | 118.25% | 43.70% |